Argenx’s (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments
Post Content Read More Yahoo Finance #finance
Arthur Hayes Says $300B Liquidity Drain Is Driving Bitcoin Lower
Post Content Read More Yahoo Finance #finance
China Internet Regulation Poses New Risks for PDD Holdings (PDD)
Post Content Read More Yahoo Finance #finance
BofA Reaffirms Buy on Hesai Group (HSAI) Amid New Chips, L3 Regulation, and Growth Drivers
Post Content Read More Yahoo Finance #finance
UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform
Post Content Read More Yahoo Finance #finance
Goldman Sachs Highlights BioNTech’s (BNTX) Immuno-Oncology and ADC Pipeline
Post Content Read More Yahoo Finance #finance
Heard on the Street Thursday Recap: Gold Swings
Post Content Read More Yahoo Finance #finance
Citizens Highlights BeOne Medicines’ (ONC) $3.8B Revenue Potential for 2025
Post Content Read More Yahoo Finance #finance
EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB)
Post Content Read More Yahoo Finance #finance
Stifel Sees Sportradar (SRAD) as Buy Amid Rational Sports Betting Duopoly
Post Content Read More Yahoo Finance #finance
Bank of Thailand plans to tighten regulations on online gold trading as its price soars
Post Content Read More Yahoo Finance #finance
Bitcoin price sub $80,000? Investors flee amid tech selloff, government shutdown fears
Post Content Read More Yahoo Finance #finance
Keefe Bruyette Boosts Cipher Mining (CIFR) PT, Cites Transition Into AI Infrastructure, HPC Colocation
Post Content Read More Yahoo Finance #finance
Is CS Disco (LAW) One of the Best Performing New Tech Stocks to Buy Now?
Post Content Read More Yahoo Finance #finance
Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage
Post Content Read More Yahoo Finance #finance
Mizuho Raises SanDisk (SNDK) PT, Cites Massive NAND Pricing Tailwinds, AI Demand
Post Content Read More Yahoo Finance #finance
Crypto Sell-off Hits Corporate Treasuries as Strategy and BitMine Stocks Slide Nearly 10%
Post Content Read More Yahoo Finance #finance
Mineralys Therapeutics (MLYS) Files Lorundrostat NDA Following Positive Clinical Milestones
Post Content Read More Yahoo Finance #finance